I’m joking, kids! Nothing is falling faster than Covid vaccine effectiveness.
And unlike vaccine effectiveness, Moderna stock has a zero lower bound.
Still, these charts are stunning. Given that Moderna has close to $20 billion in vaccine sales baked in for 2022, a market cap of $58 billion suggests investors are moving closer and closer to assigning ZERO value to its mRNA technology going forward.
Moderna stock is falling faster than Covid vaccine effectiveness
I’m joking, kids! Nothing is falling faster than Covid vaccine effectiveness.
And unlike vaccine effectiveness, Moderna stock has a zero lower bound.
Still, these charts are stunning. Given that Moderna has close to $20 billion in vaccine sales baked in for 2022, a market cap of $58 billion suggests investors are moving closer and closer to assigning ZERO value to its mRNA technology going forward.
Sounds about right.
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.